Suppr超能文献

结蛋白在横纹肌肉瘤中的表达:结蛋白克隆及免疫组织化学方法的影响

Desmin expression in rhabdomyosarcoma: influence of the desmin clone and immunohistochemical method.

作者信息

Pollock L, Rampling D, Greenwald S E, Malone M

机构信息

Department of Histopathology, Great Ormond Street Hospital for Sick Children NHS Trust, London.

出版信息

J Clin Pathol. 1995 Jun;48(6):535-8. doi: 10.1136/jcp.48.6.535.

Abstract

AIM

To determine which, if any, of five commercially available desmin clones is most reliable at labelling desmin filaments and whether the enhanced polymer one step (EPOS) method of labelling is of any advantage in the routine diagnostic laboratory.

METHODS

Thirty four rhabdomyosarcomas from the files at The Hospital for Sick Children, Great Ormond Street, London, were studied. Four different desmin clones, DE-R-11, D33, DE-U-10, and PDE, were applied to each using the conventional extravidin biotin peroxidase method. The D33 clone was also applied using the EPOS method.

RESULTS

The EPOS method incorporating D33 persistently scored more cells as desmin positive and was positive in four cases which were negative on staining with the other clones.

CONCLUSIONS

The D33 desmin clone used with the EPOS method is more reliable for identifying desmin filaments in tumours than other desmin antibodies tested. Different desmin clones using a routine technique label different rhabdomyosarcoma cells and therefore it is justifiable to use more than one clone.

摘要

目的

确定市售的五种结蛋白克隆抗体中,哪一种(若有的话)在标记结蛋白丝方面最可靠,以及增强聚合物一步法(EPOS)标记法在常规诊断实验室中是否具有任何优势。

方法

对伦敦大奥蒙德街儿童医院存档的34例横纹肌肉瘤进行研究。使用传统的抗生物素蛋白生物素过氧化物酶法,将四种不同的结蛋白克隆抗体DE-R-11、D33、DE-U-10和PDE分别应用于每例样本。D33克隆抗体也采用EPOS法进行应用。

结果

采用D33的EPOS法持续将更多细胞判定为结蛋白阳性,并且在其他克隆抗体染色呈阴性的4例样本中呈阳性。

结论

与EPOS法联用的D33结蛋白克隆抗体在识别肿瘤中的结蛋白丝方面比所检测的其他结蛋白抗体更可靠。使用常规技术的不同结蛋白克隆抗体标记不同的横纹肌肉瘤细胞,因此使用一种以上的克隆抗体是合理的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5127/502683/4289e725e9b8/jclinpath00231-0044-a.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验